- Home
- INZY vs DUOT Comparison
INZY vs DUOT Comparison
Compare INZY & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INZY
- DUOT
- Stock Information
- Founded
- INZY 2015
- DUOT 1990
- Country
- INZY United States
- DUOT United States
- Employees
- INZY N/A
- DUOT N/A
- Industry
- INZY Biotechnology: Pharmaceutical Preparations
- DUOT Computer Software: Prepackaged Software
- Sector
- INZY Health Care
- DUOT Technology
- Exchange
- INZY Nasdaq
- DUOT Nasdaq
- Market Cap
- INZY 64.9M
- DUOT 66.3M
- IPO Year
- INZY 2020
- DUOT N/A
- Fundamental
- Price
- INZY $0.91
- DUOT $5.64
- Analyst Decision
- INZY Strong Buy
- DUOT Strong Buy
- Analyst Count
- INZY 10
- DUOT 2
- Target Price
- INZY $16.90
- DUOT $10.75
- AVG Volume (30 Days)
- INZY 517.6K
- DUOT 80.1K
- Earning Date
- INZY 03-10-2025
- DUOT 03-31-2025
- Dividend Yield
- INZY N/A
- DUOT N/A
- EPS Growth
- INZY N/A
- DUOT N/A
- EPS
- INZY N/A
- DUOT N/A
- Revenue
- INZY N/A
- DUOT $7,346,014.00
- Revenue This Year
- INZY N/A
- DUOT $16.88
- Revenue Next Year
- INZY N/A
- DUOT $183.85
- P/E Ratio
- INZY N/A
- DUOT N/A
- Revenue Growth
- INZY N/A
- DUOT N/A
- 52 Week Low
- INZY $0.88
- DUOT $2.03
- 52 Week High
- INZY $7.80
- DUOT $8.53
- Technical
- Relative Strength Index (RSI)
- INZY 32.10
- DUOT 44.81
- Support Level
- INZY $0.94
- DUOT $5.87
- Resistance Level
- INZY $1.03
- DUOT $6.38
- Average True Range (ATR)
- INZY 0.08
- DUOT 0.51
- MACD
- INZY 0.01
- DUOT -0.02
- Stochastic Oscillator
- INZY 13.64
- DUOT 33.76
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains while they are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.